Get the Stockscreener App
9.09
6.82%
0.58
Sanuwave Health Inc stock is traded at $9.09, with a volume of 555.63K.
It is up +6.82% in the last 24 hours and down -46.05% over the past month.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
See More
Previous Close:
$8.51
Open:
$8.62
24h Volume:
555.63K
Relative Volume:
6.17
Market Cap:
$78.16M
Revenue:
$44.33M
Net Income/Loss:
$16.05M
P/E Ratio:
27.81
EPS:
0.3269
Net Cash Flow:
$3.85M
1W Performance:
-36.79%
1M Performance:
-46.05%
6M Performance:
-71.69%
1Y Performance:
-69.59%
1-Day Range:
$8.34
$9.8699
1-Week Range:
$8.30
$15.40
52-Week Range:
$8.30
$46.59
Sanuwave Health Inc Stock (SNWV) Company Profile
Name
Sanuwave Health Inc
Sector
Industry
Phone
952-656-1029
Address
9600 W. 6TH SSTREET, EDEN PRAIRIE
Compare SNWV vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNWV
Sanuwave Health Inc
|
29.00 | 34.02M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
2.33 | 3.33B | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
6.79 | 397.06M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
20.25 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.77 | 254.39M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
46.74 | 0 | 0 | 0 | 0 | 0.00 |
Sanuwave Health Inc Stock (SNWV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | Northland Capital | Outperform |
| Jul-29-25 | Initiated | Roth Capital | Buy |
Sanuwave Health Inc Stock (SNWV) Latest News
Sanuwave cuts Q2 revenue guidance on weak equipment sales By Investing.com - Investing.com Canada
Sanuwave Health shareholders elect directors and approve auditor at annual meeting - Investing.com
Sanuwave Health Stockholders Approve Directors and Governance Matters - TipRanks
SANUWAVE Health (SNWV) Retreats From Resistance, Testing Key Support LevelsLast Point Support - newsline.com
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: Deep EPS Miss Raises Concerns Despite Stock RallyRevenue Warning Signal - newsline.com
SNWV: Director elections, auditor ratification, and executive pay were voted on; results pending - TradingView
SANUWAVE Health Inc Annual Shareholders Meeting Transcript - GuruFocus
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: Wider-than-Expected Loss Amid Pre-Commercialization PhaseConsensus Miss Rate - newsline.com
Sanuwave (SNWV) Q4 2025 Earnings Transcript - The Globe and Mail
SANUWAVE Reports Record Q4 Revenue and Surging System Sales - HarianBasis.co
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: EPS Falls Short of Estimates, Stock DeclinesAnalyst Consensus Shift - newsline.com
SANUWAVE Health (SNWV) Slips 1.14% as Stock Tests Support Near $15.65Cash Secured Put - newsline.com
SANUWAVE Health (SNWV) Shows Strength: Shares Gain Over 4% Amid Bullish Technical SetupMAMA Signal - The Legal Advocate
SNWV Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock DeclinesRevenue Guidance Update - newsline.com
SANUWAVE Health Inc. Q1 2026 Earnings: Significant EPS Miss Leads to Stock DeclineAI Trading Community - Newser
SANUWAVE Health Q1 2026 Earnings: EPS Misses Estimates by 283.8%, Revenue Not Disclosed - Newser
SANUWAVE Health (SNWV) Slips as Stock Tests Key Support Levels Near $16Ascending Triangle - thelegaladvocate.com
SANUWAVE Health Inc. (SNWV) Slips 1.82% as Stock Nears Key Support ZoneChange of Character - Newser
Shareholders Shouldn’t Be Too Comfortable With SANUWAVE Health's (NASDAQ:SNWV) Strong Earnings - Sahm
SANUWAVE Health (SNWV) Q1 2026 Results Miss Estimates — EPS $-0.18 vs $-0.05Debt/EBITDA - Newser
Number of shareholders of SANUWAVE Health, Inc. – NASDAQ:SNWV - TradingView
Sanuwave forecasts Q2 revenue of $11.1M-$11.6M while maintaining $51M-$55M full-year outlook - MSN
Is SANUWAVE Health (SNWV) 212.1% Overvalued After Q1 2026 EPS -$ - GuruFocus
Sanuwave Health Reports Record Q1 2026 Revenue of $9.6 Million - HarianBasis.co
SANUWAVE Health Reports Record Revenue for First Quarter 2026 - HarianBasis.co
SANUWAVE Health Inc (SNWV) Q1 2026 Earnings Call Highlights: Rec - GuruFocus
SANUWAVE Health Balances Growth, Margin Pressure in Q1 - TipRanks
Sanuwave (SNWV) Q1 2026 Earnings Transcript - AOL.com
Sanuwave Health Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: SANUWAVE Health sees Q1 revenue growth in 2026 - Investing.com Nigeria
SNWV: Record Q1 revenue and strong outlook signal recovery and growth momentum for 2026 - TradingView
SANUWAVE Health Inc Reports Q1 2026 Results: Full Earnings Call Transcript - Yahoo Finance
SANUWAVE Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
SANUWAVE Health, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SNWV) 2026-05-13 - Seeking Alpha
SANUWAVE Health, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
SNWV: Q1 2026 revenue up 3% year-over-year; FY 2026 revenue guidance raised to $51–$55M - TradingView
Sanuwave (SNWV) Reports Q1 Revenue Growth Amid Signs of Recovery - GuruFocus
Sanuwave Health Inc. (SNWV) reports Q1 loss, beats revenue estimates - MSN
Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates - sharewise.com
Sanuwave Health (SNWV) Projects Revenue Growth for FY26 - GuruFocus
SANUWAVE Health Backs 2026 Rev $51M-$55M >SNWV - Moomoo
Sanuwave Health Q1 Net Income USD -1.4 Million - TradingView
Sanuwave Healthforecasts Q2 2026 revenue $11.1-$11.6 million, FY2026 revenue $51.0-$55.0 millionSEC filing - marketscreener.com
SANUWAVE Health Q1 swings to operating loss as margins fall - TradingView
Sanuwave Announces Revenues and Financial Results for Q1 FY2026 - marketscreener.com
Press Release: Sanuwave Announces Revenues and Financial Results for Q1 FY2026 - Moomoo
According to documents submitted to the U.S. Securities and Exchange Commission (SEC), Sanuwave Health Inc has released its financial outlook. - Bitget
SNWV: Q1 2026 set a revenue record with improved net loss and strong outlook for continued growth - TradingView
Sanuwave Health Inc Stock (SNWV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sanuwave Health Inc Stock (SNWV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
May 01 '26 |
Sale |
16.11 |
10,581 |
170,465 |
5,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 28 '26 |
Sale |
18.47 |
46,288 |
854,819 |
7,500 |
| Opaleye Management Inc. | 10% Owner |
Apr 29 '26 |
Sale |
17.25 |
24,360 |
420,152 |
6,500 |
| Opaleye Management Inc. | 10% Owner |
Apr 17 '26 |
Sale |
20.46 |
16,267 |
332,841 |
10,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 21 '26 |
Sale |
20.50 |
202 |
4,142 |
954,798 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 11 '25 |
Sale |
31.28 |
13,500 |
422,277 |
70,499 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 12 '25 |
Sale |
21.04 |
6,500 |
136,789 |
63,999 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 08 '25 |
Sale |
30.75 |
125,400 |
3,856,050 |
881,390 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 09 '25 |
Sale |
30.58 |
8,785 |
268,679 |
872,605 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 10 '25 |
Sale |
30.39 |
8,625 |
262,129 |
863,980 |
2.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):